Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Other Non-Current Liabilities (2019 - 2021)

IDEAYA Biosciences' Other Non-Current Liabilities history spans 3 years, with the latest figure at $6000.0 for Q3 2021.

  • For Q3 2021, Other Non-Current Liabilities fell 50.0% year-over-year to $6000.0; the TTM value through Sep 2021 reached $6000.0, down 50.0%, while the annual FY2020 figure was $12000.0, 64.71% down from the prior year.
  • Other Non-Current Liabilities for Q3 2021 was $6000.0 at IDEAYA Biosciences, roughly flat from $6000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $60000.0 in Q2 2019 and bottomed at $6000.0 in Q1 2021.
  • The 3-year median for Other Non-Current Liabilities is $14000.0 (2020), against an average of $22500.0.
  • The largest annual shift saw Other Non-Current Liabilities tumbled 76.92% in 2020 before it tumbled 50.0% in 2021.
  • A 3-year view of Other Non-Current Liabilities shows it stood at $34000.0 in 2019, then tumbled by 64.71% to $12000.0 in 2020, then crashed by 50.0% to $6000.0 in 2021.
  • Per Business Quant, the three most recent readings for IDYA's Other Non-Current Liabilities are $6000.0 (Q3 2021), $6000.0 (Q2 2021), and $6000.0 (Q1 2021).